Back to STOK

Lynx1 Capital Management LP → STOK

Lynx1 Capital Management LP STOK Position History

Stoke Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$101.3M
Q3 2026
Peak value
$171.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$171.5M
Q1 2026$155.1M
Q2 2026$132.1M
Q2 2026$132.1M
Q3 2026$101.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$101.3M3.90M——
Q2 2026$132.1M4.04M——
Q2 2026$132.1M4.04M——
Q1 2026$155.1M4.76M——
Q4 2025$171.5M5.40M——

Other funds holding STOK

Other Lynx1 Capital Management LP positions

GHRS

GH RESEARCH PLC

$356.5M
GHRS

GH RESEARCH PLC

$311.4M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
GHRS

GH RESEARCH PLC

$151.3M
CGEM

CULLINAN THERAPEUTICS INC

$137.6M
GHRS

GH RESEARCH PLC

$132.2M
CGEM

CULLINAN THERAPEUTICS INC

$127.4M